SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients

IF 2.1 3区医学 Q2 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING

Clinical radiology Pub Date : 2025-02-01 DOI:10.1016/j.crad.2024.106777

S. Siddiqui , M. Povey , M. Rowland , S. Sharma

{"title":"SCOUT® radar reflectors for impalpable lesion localisation in the breast and axilla: our experience in the first 500 patients","authors":"S. Siddiqui , M. Povey , M. Rowland , S. Sharma","doi":"10.1016/j.crad.2024.106777","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>This study aimed to detail our experience of using SCOUT® radar reflector for lesion localisation in the breast and axilla.</div></div><div><h3>Materials and methods</h3><div>This is a prospective cohort study describing our clinical experience with the first 500 patients who received SCOUT® to localise lesions in the breast and axilla (from 23 July 2020 to 4 April 2022). Study measures include patient demographics, lesion location, diagnostic pathways (screening or symptomatic), imaging, and surgical and pathology outcomes.</div></div><div><h3>Results</h3><div>Of the 500 patients, most patients (n = 424; 84.8%) had a single device inserted. A total of 361 had SCOUT® inserted under ultrasound guidance, 128 under stereotactic guidance, and 11 under dual mammographic and ultrasonographic guidance. We successfully inserted SCOUT® in 33 patients for lymph node identification for potential targeted axillary dissection. The mean time between SCOUT® insertion and the planned surgical procedure was 40.6 days.</div></div><div><h3>Conclusion</h3><div>Our results suggest that SCOUT® is a promising preoperative localisation device for nonpalpable breast and axillary lesions. Its implementation has the potential to optimise the clinical workflow by eliminating the need for a separate localisation procedure using conventional localisation markers and streamlining the treatment pathway.</div></div>","PeriodicalId":10695,"journal":{"name":"Clinical radiology","volume":"81 ","pages":"Article 106777"},"PeriodicalIF":2.1000,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical radiology","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0009926024006640","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}

引用次数: 0

Abstract

Aim

This study aimed to detail our experience of using SCOUT® radar reflector for lesion localisation in the breast and axilla.

Materials and methods

This is a prospective cohort study describing our clinical experience with the first 500 patients who received SCOUT® to localise lesions in the breast and axilla (from 23 July 2020 to 4 April 2022). Study measures include patient demographics, lesion location, diagnostic pathways (screening or symptomatic), imaging, and surgical and pathology outcomes.

Results

Of the 500 patients, most patients (n = 424; 84.8%) had a single device inserted. A total of 361 had SCOUT® inserted under ultrasound guidance, 128 under stereotactic guidance, and 11 under dual mammographic and ultrasonographic guidance. We successfully inserted SCOUT® in 33 patients for lymph node identification for potential targeted axillary dissection. The mean time between SCOUT® insertion and the planned surgical procedure was 40.6 days.

Conclusion

Our results suggest that SCOUT® is a promising preoperative localisation device for nonpalpable breast and axillary lesions. Its implementation has the potential to optimise the clinical workflow by eliminating the need for a separate localisation procedure using conventional localisation markers and streamlining the treatment pathway.

查看原文本刊更多论文

SCOUT®雷达反射器用于乳房和腋窝不可触摸病变定位：我们在前500名患者中的经验。

目的：本研究旨在详细介绍我们使用SCOUT®雷达反射器进行乳房和腋窝病变定位的经验。材料和方法：这是一项前瞻性队列研究，描述了我们对前500名接受SCOUT®定位乳房和腋窝病变的患者的临床经验（从2020年7月23日至2022年4月4日）。研究措施包括患者人口统计学、病变位置、诊断途径（筛查或症状）、影像学、手术和病理结果。结果：500例患者中，大多数患者(n = 424；84.8%)植入了单个设备。361例在超声引导下置入SCOUT®，128例在立体定向引导下置入，11例在乳房x线和超声双重引导下置入。我们成功地在33例患者中插入SCOUT®用于淋巴结识别，以进行潜在的靶向腋窝清扫。SCOUT®插入和计划手术之间的平均时间为40.6天。结论：我们的研究结果表明SCOUT®是一种很有前途的术前定位装置，用于不可触及的乳房和腋窝病变。它的实施有可能通过消除使用传统定位标记进行单独定位程序的需要和简化治疗途径来优化临床工作流程。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical radiology 医学-核医学

CiteScore

4.70

自引率

3.80%

发文量

528

审稿时长

76 days

期刊介绍： Clinical Radiology is published by Elsevier on behalf of The Royal College of Radiologists. Clinical Radiology is an International Journal bringing you original research, editorials and review articles on all aspects of diagnostic imaging, including: • Computed tomography • Magnetic resonance imaging • Ultrasonography • Digital radiology • Interventional radiology • Radiography • Nuclear medicine Papers on radiological protection, quality assurance, audit in radiology and matters relating to radiological training and education are also included. In addition, each issue contains correspondence, book reviews and notices of forthcoming events.